Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04883099 · ClinicalTrials.gov registry record · NA
APIOC for Presbyopia and APIOC for Presbyopia With Astigmatism
A NA study, sponsored by Lentechs.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT04883099: Completed NA study, sponsored by Lentechs.
NCT04883099 is a NA study that has completed, run by Lentechs. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04883099, a NA study, has completed, sponsored by Lentechs.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
Vision and comfort, both objective and subjective, will be assessed for single vision contact lens wearers for either the APIOC™ for Presbyopia or the APIOC™ for Presbyopia Astigmatism contact lenses.
Primary Outcome
High and Low Contrast LogMAR
Interventions
- DEVICE APIOC for Presbyopia and APIOC for Presbyopia for Astigmatism
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2021-05-06 |
| Est. Completion | 2021-10-31 |
| Phase | NA |
What the finished NCT04883099 record still lists
NCT04883099 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which APIOC for Presbyopia and APIOC for Presbyopia for Astigmatism is the first listed.
NCT04883099 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04883099 about?
NCT04883099 is a clinical study titled "APIOC for Presbyopia and APIOC for Presbyopia With Astigmatism". Vision and comfort, both objective and subjective, will be assessed for single vision contact lens wearers for either the APIOC™ for Presbyopia or the APIOC™ for Presbyopia Astigmatism contact lenses.
What is the current status of trial NCT04883099?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2021-05-06. Estimated completion is 2021-10-31.
What interventions are being tested in trial NCT04883099?
The interventions under investigation include: APIOC for Presbyopia and APIOC for Presbyopia for Astigmatism (DEVICE).
Who is sponsoring clinical trial NCT04883099?
This trial is sponsored by Lentechs, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04883099's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI